Viemed Healthcare: Maintaining 'Buy' Rating Post Q1 On Improving Capital Efficiency
Viemed Healthcare has seen significant growth, with shares increasing by 28% since the start of the year. The company's Q1 revenues rose by 28% to $75.41 million, exceeding expectations, and it has adjusted its 2026 revenue guidance upwards. The shift towards less capital-intensive service lines is enhancing capital efficiency and supporting sustainable free cash flow.
- ▪Viemed Healthcare's shares have increased by 28% since January.
- ▪The company's Q1 revenues surged to $75.41 million, beating expectations by 28%.
- ▪Viemed has raised its 2026 revenue guidance to between $312 million and $320 million.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4905902-viemed-healthcare-stock-maintaining-buy-rating-post-q1-on-improving-capital-efficiency"},"author":{"@type":"Person","name":"Individual Trader","url":"https://seekingalpha.com/author/individual-trader"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
